NCT06806761

Brief Summary

This study aims to understand how balance and walking abilities recover after a stroke, using innovative tools like an interactive assessment game. By observing patients over time, the investigators seek to identify recovery patterns that can improve rehabilitation strategies tailored to individual needs. Interacting with a game designed to assess balance and movement, participants will perform tasks involving sitting balance, standing balance, and gait initiation. The game measures aspects like reaction time, movement accuracy, and postural control, providing detailed insights into recovery progress. These data will validate prediction models to support personalized care. The study is non-invasive, does not interfere with usual care, and prioritizes patient safety. The investigators' ultimate goal is to enhance the understanding of recovery, leading to better care and improved quality of life for stroke survivors.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
29mo left

Started Jan 2025

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress40%
Jan 2025Dec 2028

First Submitted

Initial submission to the registry

November 29, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

January 7, 2025

Completed
28 days until next milestone

First Posted

Study publicly available on registry

February 4, 2025

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 9, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 9, 2028

Last Updated

July 16, 2026

Status Verified

July 1, 2026

Enrollment Period

3.9 years

First QC Date

November 29, 2024

Last Update Submit

July 14, 2026

Conditions

Keywords

strokebalancelongitudinalgait initiation

Outcome Measures

Primary Outcomes (4)

  • Postural control

    Postural control during dynamic tasks (sitting, standing, gait initiation) measured using wearable sensors (e.g., IMUs) and other biomechanical measurement systems (e.g., force plates, Kinect cameras).

    Baseline, 5, 8, 12, and 24 weeks post-stroke (or until discharge)

  • Weight distribution

    Weight distribution during balance and movement tasks (standing, gait initiation) using force plates.

    Baseline, 5, 8, 12, and 24 weeks post-stroke (or until discharge)

  • Movement coordination

    Movement coordination assessed during functional motor tasks (sitting, standing, gait initiation) using wearable sensors (e.g., IMUs), force plates, and Kinect camera.

    Baseline, 5, 8, 12, and 24 weeks post-stroke (or until discharge)

  • Neuromuscular activity

    Neuromuscular activity evaluated during dynamic tasks (sitting, standing, gait initiation) using muscle activity measurement systems (e.g., EMG sensors).

    Baseline, 5, 8, 12, and 24 weeks post-stroke (or until discharge)

Secondary Outcomes (15)

  • Reaction time

    Baseline, 5, 8, 12, and 24 weeks post-stroke (or until discharge)

  • Movement time

    Baseline, 5, 8, 12, and 24 weeks post-stroke (or until discharge)

  • Reaching or stepping accuracy

    Baseline, 5, 8, 12, and 24 weeks post-stroke (or until discharge)

  • Upper limb dynamics

    Baseline, 5, 8, 12, and 24 weeks post-stroke (or until discharge)

  • Daily activity monitoring

    Baseline, 5, 8, 12, and 24 weeks post-stroke (or until discharge)

  • +10 more secondary outcomes

Study Arms (1)

Patients in the first 6 months after stroke

Participants will be adults aged 18 years or older who have experienced a supratentorial ischaemic or haemorrhagic stroke and are within eight weeks after stroke onset at inclusion. Inclusion will occur as soon as feasible after admission to the rehabilitation hospital. Participants must be able to understand and perform the study procedures feasible at each assessment, based on the advice of the treating therapist(s) and/or physician(s). Written informed consent will be obtained from the participant or, where applicable, a legally authorised representative. Exclusion criteria are neurological or orthopaedic comorbidities unrelated to stroke that significantly impair motor function, severe medical conditions that could compromise safety, major deficits in communication, memory or understanding that prevent participation, and insufficient comprehension of Dutch, French, German or English. Independent walking, standing balance and ability to perform the exergame tasks are not required.

Other: Longitudinal prospective cohort study

Interventions

Description: Patients after stroke who meet the eligibility criteria will be assessed three to five times during the first six months after stroke, depending on the timing of inclusion.

Patients in the first 6 months after stroke

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients in the first 6 months after stroke: Participants will be adults aged 18 years or older who have experienced a supratentorial ischaemic or haemorrhagic stroke and are included within eight weeks after stroke onset. They will be followed during the first six months after stroke.

You may qualify if:

  • Adult aged ≥18 years
  • Diagnosis of a supratentorial ischaemic or haemorrhagic stroke
  • Able to understand and perform the study procedures that are feasible at a given assessment time point, based on the advice of the treating therapist(s) and/or physician(s)
  • Written informed consent provided by the participant or, where applicable, by a legally authorised representative

You may not qualify if:

  • Neurological or orthopaedic comorbidities unrelated to stroke that significantly impair motor function
  • Severe medical conditions that could compromise safety during the assessments
  • Major deficits in communication, memory or understanding that prevent participation in the study procedures
  • Insufficient comprehension of Dutch, French, German or English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Inkendaal rehabilitation hospital

Sint-Pieters-Leeuw, Brussels Capital, 1602, Belgium

RECRUITING

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Central Study Contacts

Marc Degelaen

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
24 Weeks
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

November 29, 2024

First Posted

February 4, 2025

Study Start

January 7, 2025

Primary Completion (Estimated)

December 9, 2028

Study Completion (Estimated)

December 9, 2028

Last Updated

July 16, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will share

This study is part of the EU Horizon 2020 TARGET project, following its DMP to ensure data is handled ethically, legally, and sustainably in line with FAIR principles (Findability, Accessibility, Interoperability, Reusability). The plan ensures systematic organization, quality consistency via standardized procedures, and compliance with GDPR, national laws, and EU requirements. Personal data is processed securely, only when necessary for project objectives, with approvals and written consent from participants. Methods include interviews, surveys, workshops, and questionnaires. Data is stored with robust backup and preservation strategies to prevent loss and ensure future usability. Sharing is (currently) restricted to the consortium under a signed data transfer agreement, with external sharing undecided. Data not publicly available includes: third-party data without permission for public release, data compromising IP protection, and participant data that cannot be fully anonymized.

Shared Documents
STUDY PROTOCOL, SAP, CSR

Locations